外伤性白内障摘除术中注射曲安奈德预防前房渗出的临床疗效  

Clinical study on the triamcinolone acetonide injection to inhibit anterior chamber fibrin exudation after traumatic cataract extraction

作　　者：纪虹[1] 薛艳[1] 徐晖[1] 

机构地区：[1]中国广东省珠海市人民医院眼科,519000

出　　处：《国际眼科杂志》2009年第5期958-959,共2页International Eye Science

摘　　要：目的:研究曲安奈德(triamcinolone acetonide,TA)在外伤性白内障摘除术中预防前房渗出的疗效。方法:将46例46眼外伤性白内障患者随机分为两组,每组23例,行白内障摘除术,人工晶状体植入囊袋后向实验组前房注入TA,对照组不注射。术后观察前房内纤维蛋白渗出情况,视力恢复状况及眼压变化等。结果:实验组的平均渗出时间、渗出度,视力恢复与对照组有显著性差异(P<0.05),1mo后复查眼压,两组并无显著差异。结论:TA应用于外伤性白内障摘除术可预防前房渗出,并且视力恢复良好,不良反应较少,无眼压升高,值得推广。AIM： To investigate the efficiency and safety of anterior chamber injection of triamcinolone acetonide （TA） for the inhibition of intraocular fibrin exudates after traumatic cataract extraction. METHODS, Forty-six cases （46 eyes） of traumatic cataract were divided into 2 groups at random, 23 cases in the study group were performed with small incision cataract extraction and IOL implantation and anterior vitrectomy. 0. 1mL （2rag） TA was injected into vitreous cavity intraoperative; 23 cases in control group were performed the same operation but were not injected TA. We observed the changes of anterior chamber fibrin exudates, vision and intraocular pressure. RESULTS, In the study group the mean time of exudation, the exudates were different from the control group, the difference between 2 groups is statistically significant （P〈 0.05）. There was no statistical difference in intraocular pressure. CONCLUSION： Anterior chamber injection of TA is an effective and safe way to inhibit fibrin exudation after traumatic cataract extraction.

关 键 词：曲安奈德 外伤性白内障摘除术 前房渗出 

分 类 号：R779.66[医药卫生—眼科] R775.206[医药卫生—临床医学]